{
  "id": "cluster_27_doc1",
  "content": "The claims audit for Q3 highlighted an increase in prior authorization requests for biologics at Mountain View Regional. Dr. Elara Koshy noted a 28% rise in rheumatology referrals, particularly for psoriatic arthritis patients. The audit flagged Policy #BIOL-441 revisions requiring step therapy attempts before biologic approvals. Systems memo attached shows data integration gaps between Epic and the regional provider network portal.",
  "metadata": {
    "format": "audit_report"
  }
}